VC-backed Teladoc debuts IPO

Telehealth platform Teladoc has raised $156.75 million for its IPO after pricing its 8.25 million shares (originally planned at 7 million) at $19 per share. The stock began trading Wednesday on the New York Stock Exchange under the ticker symbol “TDOC.” J.P. Morgan Securities LLC and Deutsche Bank Securities Inc are the lead underwriters. Teladoc’s backers include Icon Ventures, FLAG Capital Management, Greenspring Associates, QuestMark Partners, Cardinal Partners, HLM Venture Partners, Kleiner Perkins Caufield & Byers, New Capital Partners and Trident Capital.


PURCHASE, N.Y.–(BUSINESS WIRE)–Teladoc, Inc., the first and largest telehealth platform in the United States, has priced and upsized its initial public offering from 7,000,000 to 8,250,000 shares of its common stock at a price to the public of $19.00 per share.

All of the shares are being offered by Teladoc. The underwriters for the offering also have a 30-day option to purchase up to an additional 1,237,500 shares of Teladoc common stock. The shares of common stock are expected to begin trading on the New York Stock Exchange on July 1, 2015, under the symbol “TDOC.”

J.P. Morgan Securities LLC and Deutsche Bank Securities Inc. are acting as joint book-running managers for the offering. William Blair & Company, L.L.C., Wells Fargo Securities, LLC and SunTrust Robinson Humphrey, Inc. are acting as co-managers for the offering.

A registration statement relating to these securities has been filed with and declared effective on June 30, 2015 by the Securities and Exchange Commission. This offering is being made only by means of a prospectus. A copy of the final prospectus related to the offering may be obtained, when available, from J.P. Morgan Securities LLC, Attention: Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, Phone: (866) 803-9204; or Deutsche Bank Securities Inc., Attn: Prospectus Department, 60 Wall Street, New York, New York 10005, telephone: 800-503-4611 or email: [email protected]

This press release shall not constitute an offer to sell or the solicitation of any offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification of these securities under the securities laws of any such state or jurisdiction.

Take your pick!

  • Buyouts delivers exclusive news and analysis about private equity deals, fundraising, top-quartile managers and more. Get your FREE trial or subscribe now.
  • VC Journal provides exclusive news and analysis about venture capital deals, fundraising, top-quartile investors and more. Get your FREE trial or subscribe now.